Residential Rehab

Eligible employees may be able to use FMLA leave to care for a spouse, child, or parent receiving qualifying addiction treatment when the employer, employee, family relationship, and serious-health-condition requirements are met.

The ADA can protect qualified people recovering from substance use disorder when they meet the law’s disability requirements and are not currently engaging in illegal drug use in a way excluded by the statute.

Recovery residence standards are quality and safety expectations for sober or recovery housing. They help residents and families evaluate whether a home supports recovery, operates responsibly, and maintains appropriate policies and peer-support practices.

A peer recovery specialist uses lived recovery experience to provide nonclinical support, mentoring, advocacy, resource navigation, encouragement, and connection to recovery services.

Digital therapeutics are software-based medical interventions designed to treat or manage a condition. For substance use disorders, some deliver structured cognitive behavioral therapy, contingency-management elements, or recovery support as an adjunct to clinical care.

Yes. Ketamine is being studied for several substance use disorders, including alcohol, cocaine, and opioid use disorders, but evidence remains preliminary and ketamine is not FDA-approved for addiction treatment.

Psychedelic-assisted therapy combines a psychedelic drug with structured psychological support. It is being studied for substance use disorders, but remains experimental and is not an established FDA-approved addiction treatment.

Yes. Psilocybin-assisted therapy is being studied for alcohol use disorder, but it remains investigational and is not FDA-approved for AUD.

Early randomized trials suggest semaglutide may reduce some alcohol-craving and drinking outcomes, but findings are mixed and semaglutide is not FDA-approved for alcohol use disorder.

Yes. GLP-1 receptor agonists such as semaglutide are being studied for alcohol use disorder, but they are not FDA-approved for AUD and the evidence is still emerging.